Cargando…
CRISPR-Cas9 Screening of Kaposi’s Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO1 as a Vulnerable Target of Cancer Cells
The abnormal proliferation of cancer cells is driven by deregulated oncogenes or tumor suppressors, among which the cancer-vulnerable genes are attractive therapeutic targets. Targeting mislocalization of oncogenes and tumor suppressors resulting from aberrant nuclear export is effective for inhibit...
Autores principales: | Gruffaz, Marion, Yuan, Hongfeng, Meng, Wen, Liu, Hui, Bae, Sangsu, Kim, Jin-Soo, Lu, Chun, Huang, Yufei, Gao, Shou-Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520457/ https://www.ncbi.nlm.nih.gov/pubmed/31088931 http://dx.doi.org/10.1128/mBio.00866-19 |
Ejemplares similares
-
SIRT1-mediated downregulation of p27(Kip1) is essential for overcoming contact inhibition of Kaposi's sarcoma-associated herpesvirus transformed cells
por: He, Meilan, et al.
Publicado: (2016) -
Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi’s Sarcoma-Associated Herpesvirus Latent and Lytic Replications
por: Gruffaz, Marion, et al.
Publicado: (2018) -
Targeting the Kaposi’s sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells
por: Haddad, Coral Orel, et al.
Publicado: (2021) -
Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA
por: Gruffaz, Marion, et al.
Publicado: (2020) -
Kaposi sarcoma herpesvirus pathogenesis
por: Mariggiò, Giuseppe, et al.
Publicado: (2017)